MT1 FLT3 Inhibitors for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia: Systematic Review and Meta-Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1875
https://www.valueinhealthjournal.com/article/S1098-3015(22)04080-3/fulltext
Title :
MT1 FLT3 Inhibitors for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia: Systematic Review and Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04080-3&doi=10.1016/j.jval.2022.09.1875
First page :
Section Title :
Open access? :
No
Section Order :
11427